Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-I negative patient: Case report

BMC Blood Disorders

Volumn 3, Issue , 2003, Pages

  Bollen, J M ^a   Polstra, A M ^a   van der Kuyl, A C ^a   Weel, J F ^a   Noorduyn, L A ^a   van Oers, M H J ^a   Cornelisen, M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANEMIA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; COUGHING; DRUG CHOICE; DYSPNEA; EDEMA; FEVER; HEPATOSPLENOMEGALY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY FAILURE; LYMPHADENOPATHY; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; MUSCLE WEAKNESS; NIGHT SWEAT; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; PATIENT MONITORING; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA; VIRUS DETECTION; VIRUS LOAD;

EID: 3042658239     PISSN: 14712326     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2326-3-3     Document Type: Article

References (27)

1. Frizzera G: Castleman's disease and related disorders. Semin Diagn Pathol 1988, 5:346-364.
2. Larroche C, Cacoub P, Soulier J, Oksenhendler E, Clauvel JP, Piette JC, Raphael M: Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol 2002, 69:119-126.
3. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, D'Agay M-F, Clauvel J-P, Raphael M, Degos L, Sigaux F: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86:1276-1280.
4. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C: Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A 1999, 96:4546-4551.
5. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C: HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000, 95:1406-1412.
6. Amin HM, Medeiros LJ, Manning JT, Jones D: Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease. Am J Surg Pathol 2003, 27:91-100.
7. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas. N Engl J Med 1995, 332:1186-1191.
8. Uccini S, Ruco LP, Monardo F, Stoppacciaro A, Dejana E, La Parola IL, Cerimele D, Baroni CD: Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Pathol 1994, 173:23-31.
9. Parravinci C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y: Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol 1997, 151:1517-1522.
10. Chadburn A, Cesarman E, Nador RG, Liu YF, Knowles DM: Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus. Cancer 1997, 80:788-797.
11. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD: Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001, 92:670-676.
12. Polstra AM, van den Burg R, Goudsmit J, Cornelissen M: Human Herpesvirus 8 Load in Matched Serum and Plasma Samples of Patients with AIDS-Associated Kaposi's Sarcoma. J Clin Microbiol 2003, 41:5488-5491.
13. Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, Du Mond C., Mamelok RD, Henry DH: Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol 1998, 16:2445-2451.
14. Nunez M, Machuca A, Soriano V, Podzamczer D, Gonzalez-Lahoz J: Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx/KS Spanish Study Group. AIDS 2000, 14:913-919.
15. Prins JM, Sol CJA, Renwick N, Goudsmit J, Veenstra J, Reiss P: Favourable effect of chemotherapy on clinical symptoms and human herpesvirus-8 DNA load in a patient with Kaposi's sarcoma presenting with fever and anemia. Eur Clin Microbiol Infect Dis 1999, 18:499-502.
16. Wit FWN, Sol CJA, Renwick N, Roos MTL, Pals ST, Van, Leeuwen R, Goudsmit J, Reiss P: Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy [2]. AIDS 1998, 12:218-219.
17. Boivin G, Cote S, Cloutier N, Abed Y, Maguigad M, Routy JP: Quantification of human herpesvirus 8 by real-time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease. J Med Virol 2002, 68:399-403.
18. Pellet C, Chevret S, Blum L, Gauville C, Hurault M, Blanchard G, Agbalika F, Lascoux C, Ponscarme D, Morel P, Calvo F, Lebbe C: Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. J Invest Dermatol 2001, 117:858-863.
19. Grandadam M, Dupin N, Calvez V, Gorin I, Blum L, Kernbaum S, Sicard D, Buisson Y, Agut H, Escande JP, Huraux JM: Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. J Infect Dis 1997, 175:1198-1201.
20. De Jong RB, Kluin PM, Rosati S, Van Haelst PL, Sprenger HG, Van Spronsen DJ: Sustained high levels of serum HHV-8 DNA years before multicentric Castleman's disease despite full suppression of HIV with highly active antiretroviral therapy. AIDS 2003, 17:1407-1408.
21. Pellet C, Chevret S, Frances C, Euvrard S, Hurault M, Legendre C, Dalac S, Farge D, Antoine C, Hiesse C, Peraldi MN, Lang P, Samuel D, Calmus Y, Agbalika F, Morel P, Calvo F, Lebbe C: Prognostic value of quantitative Kaposi sarcoma - associated herpesvirus load in posttransplantation Kaposi sarcoma. J Infect Dis 2002, 186:110-113.
22. Lessan-Pezeshki M, Einollahi B, Khatami MR, Mahdavi M: Kidney transplantation and Kaposi's sarcoma: review of 2050 recipients. Transplant Proc 2001, 33:2818.
23. Mandel C, Silberstein M, Hennessy O: Case report: fatal pulmonary Kaposi's sarcoma and Castleman's disease in a renal transplant recipient. Br J Radiol 1993, 66:264-265.
24. Cagirgan S, Cirit M, Ok E, Sencan M, Hekimgil M, Unsal A, Saydam G, Tokat Y: Castleman's disease in a renal allograft recipient. Nephron 1997, 76:352-353.
25. Vial T, Descotes J: Immunosuppressive drugs and cancer. Toxicology 2003, 185:229-240.
26. Renwick N, Halaby T, Weverling GJ, Dukers NHTM, Simpson, GR, Coutinho RA, Lange LMA, Schulz TF, Goudsmit J: Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998, 12:2481-2488.
27. Kapelushnik J, Ariad S, Benharroch D, Landau D, Moser A, Delsol G, Brousset P: Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol 2001, 113:425-428.